FDA Long-Term Globalization Strategy Under Development
This article was originally published in The Pink Sheet Daily
Executive Summary
"Third-party inspection programs need to be a bigger part of the discussion so that we don't have to do the work all ourselves," said John Taylor, FDA acting principal deputy commissioner. "We simply cannot do it alone."
You may also be interested in...
International "Comparability" Of Regulatory Standards May Be FDA's Solution To GMP Oversight
FDA may begin to rely on foreign government oversight of manufacturing even if the standards for the overseas regulators do not exactly match those in the U.S
International "Comparability" Of Regulatory Standards May Be FDA's Solution To GMP Oversight
As the agency struggles to adapt to globalization of the pharmaceutical supply chain, exact harmonization of regulatory standards may not be a goal worth pursuing.
International "Comparability" Of Regulatory Standards May Be FDA's Solution To GMP Oversight
As the agency struggles to adapt to globalization of the pharmaceutical supply chain, exact harmonization of regulatory standards may not be a goal worth pursuing.